Lastet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lastet, covering 2024-06-17 to 2024-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer [Phase 2]